MacroGenics Announces Presentations at the 2020 ASCO Annual Meeting

NEXT STORY
Atreca, BeiGene, and IGM Biosciences Agree to Collaborate on Novel Antibody Treatment for COVID-19
PREV STORY
Alimera Sciences Announces First Quarter 2020 Financial Results and Provides Corporate Update
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Kiniksa Announces Upcoming Presentation on Mavrilimumab in COVID-19 Pneumonia and Hyperinflammation at the European E-Congress of Rheumatology 2020

author_avatar
NASDAQ Market News

Rafael Pharmaceuticals Provides Update on Pivotal Phase 3 Clinical Trial in Patients with Metastatic Pancreatic Cancer and Interim Analysis of Pivotal Phase 3 Clinical Trial in Patients with Relapsed or Refractory Acute Myeloid Leukemia

author_avatar
NASDAQ Market News

Brandywine Realty Trust Announces First Quarter Results and Adjusts 2020 Guidance

author_avatar
NASDAQ Market News